-

Kit Check Extends Partnership with Premier Inc. in Multi-Year Contract to Further Advance Pharmacy Visibility with Diversion Detection Software and Medication Management

WASHINGTON, D.C.--(BUSINESS WIRE)--Kit Check, the leader in automated and intelligent medication management solutions, today announced that Premier Inc. has extended its sole source partnership with the company for its Bluesight™ for Controlled Substances (BCS) solution as well as its namesake kit and tray processing system. Premier, one of the nation’s largest group purchasing organizations, is a leading healthcare improvement company uniting more than 4,000 U.S. hospitals and health systems and more than 175,000 other providers and organizations.

Both Bluesight™ for Controlled Substances, an artificial intelligence-based medication diversion detection and discrepancy resolution solution, and Kit Check’s RFID-based inventory management solution provide valuable insight and actionable data throughout the medication life cycle. From visibility that tracks drugs from production to when they reach the patient, to tagging visibility that ensures the right drug is in the right place at the right time for the right patient, the partnership renewal creates an accountable data journey for drugs and their origins.

“We are excited about Premier’s renewed commitment to helping their members gain insight into controlled substance use across facilities and the prevention of potential drug theft,” said Kevin MacDonald, CEO and co-founder of Kit Check. “As the sole source vendor for Premier, Kit Check is streamlining their pharmacy management approach, which creates a more efficient, safe environment for their members and patients alike.”

Bluesight™ for Controlled Substances is a source-system agnostic platform that provides 100 percent audit of the OR and nursing floors as well as in the pharmacy, allowing healthcare organizations to get ahead of diversion events before they happen. Kit Check’s RFID-based medication inventory tracking and automated tray processing uses RFID tags combined with automation to enable hospital pharmacists to easily track drugs coming in and out of their doors, and removes the downtime associated with shortages and recalls.

“We are thrilled to continue our partnership with Kit Check’s Bluesight for Controlled Substances diversion software and their kit and tray processing tools,” said Chris Jones, R.Ph., Director, Pharmacy Automation and Technology at Premier, based in Charlotte, N.C. “They are a clear leader in medication tracking and machine learning for controlled substances and provide a powerful service for our Pharmacy Member health systems.”

To learn more about Kit Check’s solutions, please visit www.kitcheck.com

About Kit CheckTM

Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking medication intelligence platforms provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 500 U.S. and Canadian hospital partners have tracked more than 100 million medications using Kit Check’s RFID product. Bluesight™ for Controlled Substances software is currently in use in more than 120 hospitals including full health system implementations, with nearly 11 million cases tracked, and was ranked #1 in the Drug Diversion Monitoring category in the 2019 Best in KLAS report. More information about Kit Check and our software solutions can be found at kitcheck.com.

About Premier

Premier Inc. (NASDAQ: PINC) is a healthcare improvement company uniting an alliance of approximately 4,000 U.S. hospitals and health systems and more than 175,000 other providers and organizations. As an industry leader, Premier has created one of the most comprehensive databases of actionable data, clinical best practices and efficiency improvement strategies.

Our award-winning and revolutionary technologies enable our members to collaborate more easily and efficiently. Our goal is to improve our members’ quality outcomes, while safely reducing costs. By engaging members and revealing new opportunities, we empower the alliance to improve the performance of healthcare organizations, helping them do what they do best, Heal First™. Named one of the World’s Most Ethical Companies® 12 years in a row, we are well-equipped to help health systems thrive. Premier. Transforming Healthcare Together.

Contacts

Jill Gross for Kit Check
kitcheck@matternow.com
(978) 518-4528

Kit Check


Release Summary
Kit Check extends partnership with Premier Inc. in multi-year contract to further advance pharmacy visibility
Release Versions

Contacts

Jill Gross for Kit Check
kitcheck@matternow.com
(978) 518-4528

More News From Kit Check

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

ALEXANDRIA, Va.--(BUSINESS WIRE)--BluesightⓇ, The Medication Intelligence™ Company, today published the results of a recent survey measuring U.S. consumers’ trust in the U.S. healthcare system and pharmaceutical industry, which revealed that trust in both is below average. The study also explored how prior knowledge about drug diversion – among other factors – may impact patient perception and decisions about where to seek care. “Through our suite of software solutions, Bluesight aims to provid...

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ

LAS VEGAS--(BUSINESS WIRE)--Kit Check today announced that it has rebranded as BluesightⓇ, The Medication Intelligence™ Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected. Founded in 2011, Bluesight provides unit-level visibility of pharmaceutical products from manufacturing plant to patient, addressing challenges suc...

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health sy...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.